Maybe they are wanting to avoid the bloodbath today? In the past...

Maybe they are wanting to avoid the bloodbath today?

In the past they have had trading halts for acquisitions, signings or SPP - but not likely SPP this time as just completed one and have $12m in the bank.

Could relate to one of these key milestones for 2018 in the last investor presentation (note quarters are for CY):
* Mernova Medicinal facility comes online for medicinal cannabis and adult recreational market delivering first revenues in Canada [expected May 2018]
* First revenues from cannaQIX®10 in the area of anxiety and stress from Q2 launch in Switzerland and Q3 launch in the UK
* Introduction of cannaQIX® 50 to Australia and New Zealand markets in Q3 2018
* Launch additional anibidiol® (animal health) formulations in Switzerland with potential for expansion into other countries
* Expansion of cannaQIX commercialisation into targeted, key European countries
* First product launches from Lifestyle portfolio including cannabis derived beverages and cannabis terpene chocolates into various markets delivering initial revenues
* First revenues from Kunna S.A.S, Columbian subsidiary in Q4 2018